These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 6099364

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL, Lu GH, Klutchko SR, Batley BL, Dahring TK, Hamby JM, Hallak H, Doherty AM, Keiser JA.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [Abstract] [Full Text] [Related]

  • 28. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
    Winston JT, Olashaw NE, Pledger WJ.
    J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP, Shimizu N.
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of PDGF-induced phosphoinositide-turnover by glucopiericidin A.
    Ahn SC, Kim BY, Park CS, Lee HS, Suh PG, Ryu SH, Rho HM, Rhee JS, Mheen TI, Ahn JS.
    Biochem Mol Biol Int; 1995 Sep; 37(1):125-32. PubMed ID: 8653074
    [Abstract] [Full Text] [Related]

  • 36. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
    Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.
    Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diacylglycerol treatment rapidly decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.
    Sinnett-Smith JW, Rozengurt E.
    J Cell Physiol; 1985 Jul; 124(1):81-6. PubMed ID: 2995413
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.